Blood-Brain Barrier (BBB) disruption is an important pathophysiological process of acute
ischemic stroke (AIS), resulting in devastating malignant brain edema and hemorrhagic …

Background: Stroke has become a major problem around the world, which is one of the
main causes of long-term disability. Therefore, it is important to seek a biomarker to predict …

Objectives: Symptomatic hemorrhagic transformation (sHT) is a life-threatening complication
of acute ischemic stroke (AIS). The early identification of the patients at increased risk of sHT …

Background and purpose The relationship between neutrophil to lymphocyte ratio (NLR)
and prognosis after acute ischemic stroke (AIS) remains controversial. The aim of this cohort …

Background and aim Neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio
(LMR) are associated with clinical outcomes in malignancy, cardiovascular disease and …

Background Hemorrhagic transformation (HT) following reperfusion therapies for acute
ischaemic stroke often predicts a poor prognosis. This systematic review and meta-analysis …

Introduction The neutrophil‐to‐lymphocyte ratio (NLR) has been shown to be a marker
associated with inflammation and is independently associated with the adverse clinical …

There is an ongoing need for accurate prognostic biomarkers in the milieu of acute ischemic
stroke (AIS) receiving reperfusion therapy. Neutrophil–lymphocyte ratio (NLR) has been …

Background Biomarker screening is of major significance for the early diagnosis and
prevention of Alzheimer's disease (AD). Routine peripheral blood parameters are easy to …

Traumatic brain injury (TBI) is the leading cause of morbidity and mortality worldwide.
Several prognostic factors have been developed to predict functional outcomes and …